In this second update, we discuss the change in the organization of PROY-NOM-241-SSA1-2024 on Good Manufacturing Practices.
This regulatory update discusses how the U.S. Food and Drug Administration (FDA) recently adapted certain searches and information to highlight regulatory guidance for specific medical device types.
In this on-demand webinar, our Emergo by UL subject matter expert shares insights on Japanese regulatory requirements for medical device software.
Mexican market regulator COFEPRIS released a new draft of the NOM for Medical Device Good Manufacturing Practices, PROY-NOM-241-SSA1-2024, on July 26, 2024.
Emergo by UL human factors specialists share considerations when developing medical products and outline benefits for establishing design systems.
The regulator in Mexico, COFEPRIS, released a new draft on July 24, 2024, for the NOM for Medical Device Technovigilance, PROY-NOM-240-SSA1-2024. This draft will be open for input and comments until Sept. 29, 2024.
As reported by Emergo by UL, the Ministry of Health of Israel is implementing reforms to the registration process for medical devices and IVDs. Our first regulatory update described the three registration routes in Israel: Declaration Route, Fast-Track Route, and Normal Route. The second in the series presents details about the changes to modifications and renewals under this regulatory reform.
In this on-demand webinar, our Emergo by UL subject matter expert shares insights on how to optimize a QMS for global medical device companies.
Our due diligence services help medical device companies navigate complex regulatory requirements to avoid post-transaction complications.
We will analyze the regulatory impact of the envisioned merger or acquisition and outline a regulatory roadmap by country for prioritization.